Discern Focuses On Patient-Reported Outcome Measurement

May 2018

Recent Discern projects have focused on patient-reported outcome performance measures (PRO-PMs) and opportunities for their prioritization, development, endorsement, and implementation for various therapeutic areas. PRO-PMs are an important element of measuring progress toward a patient-centered, value-based health care system.

A recent example of Discern’s PRO-PM work is supporting the development of a patient-reported measure for multiple sclerosis (MS). Multiple sclerosis is a disease with characteristics that make it both a challenge and an important endeavor to develop quality measures that are patient-centered, and help close the quality gap for patients living with MS. The subject matter expertise of Discern staff in measure development and patient-reported measurement have been instrumental in this project. The work includes engagement with the National Quality Forum’s (NQF’s) Measure IncubatorTM, which is facilitating MS patient-centered measure development. The project is nearing the measure testing phase, where information is being generated about the measures’ feasibility and scientific soundness.

For more information on this project or to find out how Discern can help your organization reach quality measurement strategic goals, contact Discern Partner Tom Valuck, MD, JD, at tvaluck@discernhealth.com or Vice President Donna Dugan, PhD, MS, at ddugan@discernhealth.com.

Discern expands Health Economics and Outcomes Research (HEOR) capabilities for Life Sciences clients

September 2018 Health economics and outcomes research (HEOR) has long been important for health care market access outside the U.S., but it is increasingly being utilized in the U.S. as part of the mo...
Learn More

About

Capabilities

Contact Us

Insights

Guy D’Andrea Speaks About Innovative Payment Models

September 2018 Click here to view the VIDEO...
Learn More